5 Most Promising Stocks to Buy Right Now

2. Progyny, Inc. (NASDAQ:PGNY)

On May 26, 2026, Progyny, Inc. (NASDAQ:PGNY) announced that its Board of Directors approved a share repurchase program to buy back up to $200 million of the company’s common stock. The program will be funded through available cash balances.

On May 19, 2026, Canaccord upgraded Progyny, Inc. (NASDAQ:PGNY) to Buy from Hold with a price target of $30, up from $19. Canaccord said the company’s “more conservative guidance philosophy” over the past several quarters has rebuilt a track record of beating quarterly estimates. The firm also said Progyny should begin lapping unfavorable comparisons from the transition of care agreement for departing Amazon members in the second half of 2026, which could move revenue growth back to double digits. A day earlier, Barclays raised the firm’s price target on Progyny to $27 from $23 and maintained an Overweight rating after the earnings report, citing better-than-expected utilization and positive early conversations from the current selling season.

Earlier in May, Progyny, Inc. (NASDAQ:PGNY) reported Q1 adjusted EPS of 50c, ahead of the consensus estimate of 44c. Revenue totaled $328.5M, above the consensus estimate of $326.51M. CEO Pete Anevski said the company had a “strong start” to the year, with member engagement trending toward the higher end of expectations as people pursued services tied to family building, health, and well-being goals.

Progyny, Inc. (NASDAQ:PGNY) provides fertility, family-building, and women’s health benefits solutions in the United States.